Clinical trial
An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
NCT05500092 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
- Lead sponsor
- Montefiore Medical Center
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- January 25, 2023
- Completion date
- May 31, 2030
- Enrollment
- 17 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
resectable stage iia to iiib non-small cell lung cancer